NASDAQ:AKCA
Delisted
Akcea Therapeutics, Inc. Stock News
$18.17
+0 (+0%)
At Close: May 27, 2022
Axa Has $4.20 Million Stock Position in Ionis Pharmaceuticals Inc (NASDAQ:IONS)
06:42am, Tuesday, 07'th Jul 2020
Axa lowered its stake in Ionis Pharmaceuticals Inc (NASDAQ:IONS) by 62.0% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fi
Hedge Funds Keep Buying Akcea Therapeutics, Inc. (AKCA)
07:20pm, Saturday, 04'th Jul 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Oppenheimer Sticks to Its Buy Rating for Moleculin Biotech (MBRX) - Markets
04:54pm, Thursday, 02'nd Jul 2020
In a report released today, Kevin DeGeeter from Oppenheimer maintained a Buy rating on Moleculin Biotech (MBRX – Research Report),
How R&D Expenses Can Help You Pick Outperforming Stocks
12:13pm, Thursday, 02'nd Jul 2020
A simple two-rule screen can help you pick R&D-intensive stocks primed to outperform. The differences between R&D expenditures and capital expenditures vary bet
Ionis Pharmaceuticals Inc (NASDAQ:IONS) Director Breaux Castleman Sells 10,000 Shares
04:52am, Wednesday, 01'st Jul 2020
Ionis Pharmaceuticals Inc (NASDAQ:IONS) Director Breaux Castleman sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average pri
C Frank Bennett Sells 15,000 Shares of Ionis Pharmaceuticals Inc (NASDAQ:IONS) Stock
04:20am, Wednesday, 01'st Jul 2020
Ionis Pharmaceuticals Inc (NASDAQ:IONS) EVP C Frank Bennett sold 15,000 shares of the company’s stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $59.77, for a
Akebia Therapeutics (AKBA) Receives a Buy from Needham - Markets
02:54pm, Monday, 29'th Jun 2020
Needham analyst Chad Messer assigned a Buy rating to Akebia Therapeutics (AKBA – Research Report) today and set a price
Akcea Appoints Tracy Palmer Berns as Chief Compliance Officer
11:00am, Monday, 29'th Jun 2020
Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., today announced that Tracy Palmer Berns has joined the company as chief compliance officer. In this
Revance Therapeutics (RVNC) Surges: Stock Moves 5.5% Higher
01:57pm, Friday, 26'th Jun 2020
Revance Therapeutics (RVNC) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Evofem Biosciences (EVFM) Looks Good: Stock Adds 10.1% in Session
12:44pm, Friday, 26'th Jun 2020
Evofem Biosciences (EVFM) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.
Interpace Diagnostics Group (IDXG) Receives a Buy from Oppenheimer - Markets
03:51am, Friday, 26'th Jun 2020
Oppenheimer analyst Kevin DeGeeter maintained a Buy rating on Interpace Diagnostics Group (IDXG – Research Report) yesterday and set a
Autolus Therapeutics (AUTL) Gets a Buy Rating from Needham - Markets
04:51pm, Thursday, 25'th Jun 2020
Needham analyst Chad Messer maintained a Buy rating on Autolus Therapeutics (AUTL – Research Report) today and set a price
Outlook Therapeutics (OTLK) Catches Eye: Stock Jumps 7%
01:43pm, Thursday, 25'th Jun 2020
Outlook Therapeutics (OTLK) saw a big move last session, as its shares jumped 7% on the day, amid huge volumes.
Kamada (KMDA) Looks Good: Stock Adds 5.7% in Session
12:46pm, Thursday, 25'th Jun 2020
Kamada (KMDA) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Retrophin (RTRX) Looks Good: Stock Adds 5.8% in Session
12:42pm, Thursday, 25'th Jun 2020
Retrophin (RTRX) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
